Message from the Management
Break Through the Boundaries of Pharmaceuticals by Realizing “SHINKA”
Since its launch in 2007, Mitsubishi Tanabe Pharma Corporation has operated under a corporate philosophy of “contributing to the healthier lives of people around the world through the creation of pharmaceuticals." As a global research-driven pharmaceutical company, we aim to be a company that is trusted by society and is steadily moving forward to realize our vision.
With declining birthrates and an aging population, social security spending is rising, and the business environment surrounding the domestic pharmaceutical industry is changing dramatically. Internationally, pressure toward making pharmaceuticals more cost effective is also growing more than ever.
With advancements in science, molecular modalities that can be used as medicines have expanded, and it is now possible to provide therapeutic agents for diseases that have been difficult to treat until now. Meanwhile, advancement in these technologies has led to higher drug costs, and discussions on healthcare sustainability have intensified. The needs of society are not only related to the treatment of diseases by drugs, but also to how long we can live in good health with ensured quality of life, that is, to "extending healthy life expectancy." The range of needs not only encompasses prevention but also post treatment care.
Mitsubishi Tanabe Pharma focuses on Central nervous system, Immuno-inflammation, Diabetes & kidney, and Vaccines. We also focus on rare diseases for which there has thus far been no treatment. We aim to realize our management philosophy of "contributing to the healthier lives of people around the world" by creating value through innovation. We take on the challenge of creating innovation based on the company's drug discovery capabilities, and collaboration with both academic and corporate partners. To this end, we will maximize our synergies as a group company of Mitsubishi Chemical Holdings Corporation.
We will deepen and evolve our capabilities in order to provide real value for our patients and their family members and we call it “SHINKA”. As we promote reforms in this rapidly changing environment, we must always remember our values as members of a pharmaceutical company, which is built on trust of our patients, healthcare professionals and society, and contributes to the health of people around the world. With these values in mind, we will undertake our management responsibilities based on the principles of transparency and fairness.
Your continued support and guidance are greatly appreciated.
Mitsubishi Tanabe Pharma